The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors in vitro-Reference-Cited by-同舟云学术

The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors in vitro

Published:2004-11-02 Issue:6 Volume:73 Page:418-426
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Korycka Anna,Smolewski Piotr,Robak Tadeusz

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2004.00336.x/fullpdf

Reference37 articles.

1. Therapy of acute myeloid leukemia;Tallman;Cancer Control J,2001

2. New developments in the treatment of acute myelocytic leukemia;Gorin;Hematology (Am Soc Hematol Educ Program),2000

3. Farnesyl transferase inhibitors in myeloid malignancies;Lancet;Blood Rev,2003

4. Farnesyltransferase inhibitors: potential role in the treatment of cancer;Cox;Drugs,2001

5. Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignances?;Reuter;Blood,2000

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycodendrimer PPI as a Potential Drug in Chronic Lymphocytic Leukaemia. The Influence of Glycodendrimer on Apoptosis in In Vitro B-CLL Cells Defined by Microarrays;Anti-Cancer Agents in Medicinal Chemistry;2017-01

2. Targeting of CD34+CD38-cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in acute Myeloid Leukaemia;BMC Cancer;2012-09-26

3. Apoptotic gene expression under influence of fludarabine and cladribine in chronic lymphocytic leukemia-microarray study;Pharmacological Reports;2012-03

4. Ciblage de la voie de signalisation RAS pour le traitement des cancers;Bulletin du Cancer;2011-09

5. Older and New Formulations of Cladribine: Pharmacology and Clinical Efficacy in Hematological Malignancies;Frontiers in Anti-Cancer Drug Discovery;2011-03-26